DENTAL CARE +: what changed
DENTAL CARE +
Largest movements
- Cash -€77,296
down €77,296 (-92.0%), from €84,036 to €6,740
mainly Receivables within one year (-€62,027) and Trade debts (-€25,794)
- Receivables within one year +€62,027
up €62,027 (+259%), from €23,962 to €85,989
of which Trade receivables: +€61,317
- Trade debts -€25,794
no longer reported in 2024 (was €25,794)
- Profit (loss) carried forward +€10,524
up €10,524 (+15.8%), from €66,565 to €77,089
- Financial charges +€55,473
up €55,473 (+1,417%), from €3,914 to €59,387
- Depreciation -€34,875
no longer reported in 2024 (was €34,875)
- Gross operating margin +€23,794
up €23,794 (+51.6%), from €46,117 to €69,911
- Other operating charges -€2,210
no longer reported in 2024 (was €2,210)
Change in the result, 2023 to 2024
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2023 and 2024 balance sheets and the 2024 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €157,998 | €142,729 | -€15,269 | -9.7% |
| Current assets | 29/58 | €157,998 | €142,729 | -€15,269 | -9.7% |
| Amounts receivable within one year | 40/41 | €23,962 | €85,989 | +€62,027 | +259% |
| Trade receivables | 40 | - | €61,317 | +€61,317 | |
| Other amounts receivable | 41 | €23,962 | €24,672 | +€710 | +3.0% |
| Current investments | 50/53 | €50,000 | €50,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €84,036 | €6,740 | -€77,296 | -92.0% |
| Total equity and liabilities | 10/49 | €157,998 | €142,729 | -€15,269 | -9.7% |
| Equity | 10/15 | €88,565 | €99,089 | +€10,524 | +11.9% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Capital | 10 | - | €20,000 | +€20,000 | |
| Issued capital | 100 | - | €20,000 | +€20,000 | |
| Reserves | 13 | €2,000 | €2,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €2,000 | €2,000 | = | 0.0% |
| Legal reserve | 130 | - | €2,000 | +€2,000 | |
| Reserves not available under the articles | 1311 | €2,000 | - | -€2,000 | |
| Profit (loss) carried forward | 14 | €66,565 | €77,089 | +€10,524 | +15.8% |
| Amounts payable | 17/49 | €69,433 | €43,639 | -€25,794 | -37.1% |
| Amounts payable after more than one year | 17 | €20,738 | €20,738 | +€0 | 0.0% |
| Financial debts | 170/4 | €20,738 | €20,738 | +€0 | 0.0% |
| Amounts payable within one year | 42/48 | €48,695 | €22,901 | -€25,794 | -53.0% |
| Current portion of amounts payable after more than one year | 42 | €22,901 | €22,901 | +€0 | 0.0% |
| Trade debts | 44 | €25,794 | - | -€25,794 | |
| Suppliers | 440/4 | €25,794 | - | -€25,794 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €34,875 | - | -€34,875 | |
| Other operating charges | 640/8 | €2,210 | - | -€2,210 | |
| Gross operating margin | 9900 | €46,117 | €69,911 | +€23,794 | +51.6% |
| Operating profit (loss) | 9901 | €9,032 | €69,911 | +€60,879 | +674% |
| Financial income | 75/76B | €12 | - | -€12 | |
| Recurring financial income | 75 | €12 | - | -€12 | |
| Financial charges | 65/66B | €3,914 | €59,387 | +€55,473 | +1,417% |
| Recurring financial charges | 65 | €3,914 | €59,387 | +€55,473 | +1,417% |
| Profit (loss) for the period before taxes | 9903 | €5,130 | €10,524 | +€5,394 | +105% |
| Income taxes | 67/77 | -€18 | - | +€18 | |
| Profit (loss) for the period | 9904 | €5,148 | €10,524 | +€5,376 | +104% |
| Profit (loss) for the period to be appropriated | 9905 | €5,148 | €10,524 | +€5,376 | +104% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.